CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Viking Therapeutics Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes

Related Companies

Read the original article

Published by PR Newswire Biotech on September 24, 2026 11:05 AM

Read Original